新诊断间歇性跛行患者早期外周血管干预的过度使用
基于2015-2017年100% Medicare按服务付费索赔数据,分析194974例首次诊断间歇性跛行的患者,其中3.2%在诊断后6个月内接受早期外周血管干预。医师层面中位早期干预率为0%,但5.6%的医师早期干预率≥14%。在门诊手术中心或办公室提供服务的比例更高、男性、执业年限较短、农村地区及跛行患者量较低的医师更倾向于高干预率。
要点
- 仅3.2%新诊断跛行患者在6个月内接受早期外周血管干预,但医师层面存在高异常值。
- 门诊手术中心或办公室服务比例越高,医师早期干预利用率越高。
- 男性、执业年限较短、农村地区及低跛行患者量的医师早期干预率更高。
核心结论
- 基于索赔数据的实践模式指标可识别早期外周血管干预率高的异常医师。
- 鉴于SVS和Choosing Wisely倡议避免将干预作为跛行一线治疗,使用国家基准的保密数据共享项目和教育指导可能有助于解决高利用率问题。
研究设计与样本
- 回顾性队列研究,使用2015-2017年100% Medicare按服务付费索赔数据。
- 纳入194974例首次诊断间歇性跛行的患者,以及5664名诊断超过10例跛行患者且至少实施一次外周血管干预的医师。
- 早期外周血管干预定义为初始跛行诊断后6个月内进行的主动脉髂动脉或股腘动脉外周血管干预。
- 采用分层多变量逻辑回归识别与早期外周血管干预相关的医师层面因素。
主要发现
- 194974例患者中,6286例(3.2%)接受了早期外周血管干预。
- 5664名医师的中位医师层面早期外周血管干预率为0%(范围0%-58.3%)。
- 320名医师(5.6%)的早期外周血管干预率≥14%(≥均值2个标准差)。
- 调整患者特征后,门诊手术中心或办公室服务比例较高与更高的外周血管干预利用率相关( vs 0%-22%;23%-47%:aOR 1.23;48%-68%:aOR 1.49;69%-100%:aOR 1.72;所有P < .05)。
- 其他独立相关的医师因素包括男性(aOR 2.04)、执业年限较短( vs ≥31年;11-20年:aOR 1.23;21-30年:aOR 1.13)、农村位置(aOR 1.25)和较低的跛行患者量( vs ≥30例;≤17例:aOR 1.30;18-29例:aOR 1.35;所有P < .05)。
关键数值与推荐
- SVS指南和Choosing Wisely倡议推荐外周血管干预仅用于生活方式受限的跛行患者,且需在药物和运动治疗试验失败后。
- 早期外周血管干预定义为初始跛行诊断后6个月内进行的主动脉髂动脉或股腘动脉外周血管干预。
- 医师层面早期外周血管干预率≥14%被定义为异常高(≥均值2个标准差)。
临床怎么用
- 可使用索赔数据衍生的实践模式指标识别早期外周血管干预率高的异常医师。
- 针对高利用率医师,可考虑保密数据共享项目,使用国家基准进行比较。
- 结合教育指导,促进对跛行患者遵循指南的一线治疗(药物和运动治疗)后再考虑干预。
局限性
- 研究为回顾性观察性设计,可能存在未测量的混杂因素。
- 使用Medicare索赔数据,结果可能不适用于其他人群或支付体系。
- 早期外周血管干预的定义依赖于索赔编码的准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Guidelines from the Society for Vascular Surgery and the Choosing Wisely campaign recommend that peripheral vascular interventions (PVIs) be limited to claudication patients with lifestyle-limiting symptoms only after a failed trial of medical and exercise therapy. We sought to explore practice patterns and physician characteristics associated with early PVI after a new claudication diagnosis to evaluate adherence to these guidelines. METHODS: We used 100% Medicare fee-for-service claims to identify patients diagnosed with claudication for the first time between 2015 and 2017. Early PVI was defined as an aortoiliac or femoropopliteal PVI performed within 6 months of initial claudication diagnosis. A physician-level PVI utilization rate was calculated for physicians who diagnosed >10 claudication patients and performed at least one PVI (regardless of indication) during the study period. Hierarchical multivariable logistic regression was used to identify physician-level factors associated with early PVI. RESULTS: Of 194,974 patients who had a first-time diagnosis of claudication during the study period, 6286 (3.2%) underwent early PVI. Among the 5664 physicians included in the analysis, the median physician-level early PVI rate was low at 0% (range, 0%-58.3%). However, there were 320 physicians (5.6%) who had an early PVI rate ≥14% (≥2 standard deviations above the mean). After accounting for patient characteristics, a higher percentage of services delivered in ambulatory surgery center or office settings was associated with higher PVI utilization (vs 0%-22%; 23%-47%: adjusted odds ratio [aOR], 1.23; 48%-68%: aOR, 1.49; 69%-100%: aOR, 1.72; all P < .05). Other risk-adjusted physician factors independently associated with high PVI utilization included male sex (aOR, 2.04), fewer years in practice (vs ≥31 years; 11-20 years: aOR, 1.23; 21-30 years: aOR, 1.13), rural location (aOR, 1.25), and lower volume claudication practice (vs ≥30 patients diagnosed during study period; ≤17 patients: aOR, 1.30; 18-29 patients: aOR, 1.35; all P < .05). CONCLUSIONS: Outlier physicians with a high early PVI rate for patients newly diagnosed with claudication are identifiable using a claims-based practice pattern measure. Given the shared Society for Vascular Surgery and Choosing Wisely initiative goal to avoid interventions for first-line treatment of claudication, confidential data-sharing programs using national benchmarks and educational guidance may be useful to address high utilization in the management of claudication.
引用
- Hicks CW, Holscher CM, Wang P, et al. Overuse of early peripheral vascular interventions for claudication. J Vasc Surg. 2019. PMID: 31208940. doi:10.1016/j.jvs.2019.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。